Pacer Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,789,098
| Closed | -$2.63M | – | 3482 |
|
|
2025
Q1 | $2.63M | Sell |
1,789,098
-9,941,673
| -85% | -$14.6M | 0.01% | 849 |
|
|
2024
Q4 | $52M | Buy |
11,730,771
+450,949
| +4% | +$2M | 0.11% | 192 |
|
|
2024
Q3 | $46.5M | Buy |
11,279,822
+2,372,183
| +27% | +$9.77M | 0.1% | 214 |
|
|
2024
Q2 | $58.1M | Buy |
8,907,639
+1,701,452
| +24% | +$11.1M | 0.13% | 183 |
|
|
2024
Q1 | $62.8M | Buy |
+7,206,187
| New | +$62.8M | 0.14% | 171 |
|
|
2023
Q3 | – | Sell |
-2,466,228
| Closed | -$26.2M | – | 2639 |
|
|
2023
Q2 | $26.2M | Buy |
2,466,228
+204,428
| +9% | +$2.18M | 0.11% | 199 |
|
|
2023
Q1 | $23.8M | Buy |
2,261,800
+711,756
| +46% | +$7.49M | 0.1% | 203 |
|
|
2022
Q4 | $19.2M | Buy |
1,550,044
+278,591
| +22% | +$3.45M | 0.1% | 175 |
|
|
2022
Q3 | $13.2M | Buy |
1,271,453
+338,287
| +36% | +$3.5M | 0.09% | 169 |
|
|
2022
Q2 | $10.8M | Buy |
+933,166
| New | +$10.8M | 0.08% | 211 |
|
|
2021
Q2 | – | Sell |
-6,889
| Closed | -$77K | – | 1478 |
|
|
2021
Q1 | $77K | Sell |
6,889
-2,506
| -27% | -$28K | ﹤0.01% | 1332 |
|
|
2020
Q4 | $107K | Sell |
9,395
-332
| -3% | -$3.78K | ﹤0.01% | 1358 |
|
|
2020
Q3 | $87K | Buy |
+9,727
| New | +$87K | ﹤0.01% | 1270 |
|
|
2018
Q4 | – | Sell |
-11,471
| Closed | -$177K | – | 791 |
|
|
2018
Q3 | $177K | Buy |
+11,471
| New | +$177K | 0.01% | 1042 |
|
|
2018
Q1 | – | Sell |
-3,501
| Closed | -$44K | – | 1086 |
|
|
2017
Q4 | $44K | Buy |
+3,501
| New | +$44K | ﹤0.01% | 1029 |
|